Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon May 30, 2024 6:50pm
87 Views
Post# 36065408

RE:RE:RE:Epidiolex generic approved by Jazz…our partner?

RE:RE:RE:Epidiolex generic approved by Jazz…our partner?alleysome, I get the impression this lawsuit is not concluded or settled in whole, as Jazz is the Plaintiff in this action.

If in fact all of these ANDA filers were hanging their hats on something as weak as misrepresenting the number of employees Jazz had, that would be a colossal waste of both time and money. 

Jazz settling with Padagis may have been a mutual legal way of Padagis stepping away from the lawsuit, and it would be interesting to find out what "on a date that depends on the occurence of certain other events" pertains to.  

Once the expiry date for the Epidiolex patent protection reaches expiration, any one of these companies can produce and sell generic Epidiolex

What is interesting is the various deviations we are hearing about regarding some of the challengers.  Is that enough to produce their own versions of Epidiolex?   Time will tell.


<< Previous
Bullboard Posts
Next >>